PPTA Global
The Plasma Protein Therapeutics Association (PPTA) is the primary advocate for the world's leading source plasma collectors and producers of plasma-based and recombinant biological therapeutics. The medicines produced by PPTA members are used in treating life-threatening diseases and serious medical conditions including bleeding disorders, immune system deficiencies, alpha-1 antitrypsin deficiencies, burns and shock.
As the global representative for the plasma collection and therapeutics industry, PPTA works cooperatively with patient groups, policymakers, regulatory agencies and other stakeholders to address critical issues that impact the industry and patients who depend on plasma protein therapeutics. PPTA's strength lies in its membership. The Association's global and regional steering committees bring together industry experts to focus on important issues relating to the quality, safety and efficacy of plasma therapeutics.
The Plasma Protein Therapeutics Association divisions: PPTA Europe, PPTA North America, PPTA Japan and PPTA Source.